Skip to Main Content

ResMed Inc.

RMD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$RMD is featured in our Tom Carper strategy.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of RMD by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Mar 30, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 23, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 24, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jan 29, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jan 23, 2026
Kelly Morrison House / D Sale $1,001 - $15,000 Jun 04, 2025
Kelly Morrison House / D Sale $1,001 - $15,000 Jun 04, 2025
Kelly Morrison House / D Sale $1,001 - $15,000 Jun 04, 2025
Kelly Morrison House / D Sale $1,001 - $15,000 Jun 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 May 28, 2025
Kelly Morrison House / D Sale $1,001 - $15,000 Apr 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Jan 13, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 May 03, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 31, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Oct 17, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2023
Thomas R. Carper Senate / D Purchase $1,001 - $15,000 Aug 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jun 29, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 26, 2023
Ro Khanna House / D Sale $1,001 - $15,000 May 23, 2023
Ro Khanna House / D Sale $1,001 - $15,000 May 19, 2023
Thomas R. Carper Senate / D Sale (Full) $1,001 - $15,000 Jan 11, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Oct 05, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 10, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 05, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Mar 30, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 Feb 17, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 10, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 14, 2021
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Oct 26, 2021
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Peter Meijer House / R Sale $1,001 - $15,000 Feb 16, 2021
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Thomas R. Carper Senate / D Sale (Partial) $1,001 - $15,000 Jul 09, 2020
Thomas R. Carper Senate / D Sale (Partial) $1,001 - $15,000 Apr 02, 2020
RMD Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RMD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RMD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in RMD holdings by institutional investors

Quarterly net insider trading by RMD's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $40,000 Apr 20, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Veterans Health Issues
  • $110,000 Apr 20, 2026 Issue: Tariff (miscellaneous tariff bills)
  • $40,000 Jan 20, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Veterans Health Issues
  • $90,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues Tariff (miscellaneous tariff bills)
  • $20,000 Oct 20, 2025 Issue: Medicare/Medicaid
  • $40,000 Oct 16, 2025 Issue: Health Issues
  • $60,000 Jul 21, 2025 Issue: Health Issues
  • $60,000 Apr 21, 2025 Issue: Health Issues
  • $60,000 Jan 21, 2025 Issue: Health Issues
  • $60,000 Oct 21, 2024 Issue: Health Issues
  • $40,000 Jul 22, 2024 Issue: Health Issues
  • $40,000 Jan 19, 2024 Issue: Medicare/Medicaid
  • $40,000 Oct 20, 2023 Issue: Medicare/Medicaid
  • $40,000 Jul 20, 2023 Issue: Medicare/Medicaid
  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $30,000 Nov 09, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $20,000 Oct 19, 2022 Issue: Health Issues
  • $150,000 Aug 10, 2022 Issue: Health Issues
  • $180,000 Jul 28, 2022 Issue: Health Issues
  • $180,000 Jul 28, 2022 Issue: Health Issues
  • $30,000 Jul 20, 2022 Issue: Medicare/Medicaid
  • $40,000 Feb 09, 2022 Issue: Medicare/Medicaid Health Issues
  • $40,000 Oct 20, 2021 Issue: Medicare/Medicaid
  • $40,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $40,000 Apr 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $60,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 20, 2020 Issue: Health Issues
  • $60,000 Jan 20, 2020 Issue: Health Issues
  • $60,000 Oct 20, 2019 Issue: Health Issues
  • $140,000 Jul 22, 2019 Issue: Health Issues
  • $70,000 Apr 22, 2019 Issue: Health Issues
  • $60,000 Jan 22, 2019 Issue: Health Issues
  • $70,000 Oct 22, 2018 Issue: Health Issues
  • $70,000 Jul 20, 2018 Issue: Health Issues
  • $80,000 Apr 19, 2018 Issue: Health Issues
  • $20,000 Jan 22, 2018 Issue: Medicare/Medicaid
  • $60,000 Jan 18, 2018 Issue: Health Issues
  • $10,000 Oct 19, 2017 Issue: Medicare/Medicaid
  • $60,000 Oct 16, 2017 Issue: Health Issues
  • $10,000 Jul 28, 2017 Issue: Medicare/Medicaid
  • $60,000 Jul 20, 2017 Issue: Health Issues
  • $60,000 Apr 19, 2017 Issue: Health Issues
  • $20,000 Apr 19, 2016 Issue: Health Issues
  • $10,000 Oct 08, 2009 Issue: Medicare/Medicaid
  • $10,000 Jul 07, 2009 Issue: Medicare/Medicaid
  • $10,000 Apr 14, 2009 Issue: Medicare/Medicaid
  • $10,000 Jan 19, 2009 Issue: Medicare/Medicaid
  • $10,000 Oct 13, 2008 Issue: Medicare/Medicaid
  • $15,000 Jul 15, 2008 Issue: Medicare/Medicaid
  • $15,000 Apr 14, 2008 Issue: Medicare/Medicaid
  • $80,000 Feb 13, 2006 Issue: Health Issues
  • $120,000 Aug 12, 2005 Issue: Health Issues
  • $100,000 Feb 17, 2005 Issue: Health Issues

RMD Estimated quarterly lobbying spending

RMD Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RMD Income Statement
RMD Balance Sheet
RMD Cash Flow
U.S. Patents

New RMD patent grants

  • Patent Title: Headgear assembly for a respiratory mask assembly Oct. 27, 2015
  • Patent Title: Recognition system for an apparatus that delivers breathable gas to a patient Oct. 20, 2015
  • Patent Title: Delivery of respiratory therapy Oct. 20, 2015
  • Patent Title: Release mechanism for patient interface and method for releasing patient interface Oct. 06, 2015
  • Patent Title: Patient interface systems Oct. 06, 2015
  • Patent Title: Nasal mask system Oct. 06, 2015
  • Patent Title: Snoring treatment apparatus and methods of managing snorers Sep. 29, 2015
  • Patent Title: Connector for a respiratory mask and a respiratory mask Sep. 15, 2015
  • Patent Title: Cushioning structure Sep. 15, 2015
  • Patent Title: Pap system Sep. 15, 2015
  • Patent Title: Mask system Sep. 01, 2015
  • Patent Title: Method and system for motor failure detection Sep. 01, 2015
  • Patent Title: Flexible structure for mask, and method and apparatus for evaluating performance of a mask in use Aug. 18, 2015
  • Patent Title: Unobtrusive nasal mask Aug. 04, 2015
  • Patent Title: Breathable gas apparatus with humidifier Jul. 07, 2015
  • Patent Title: Forehead pad for respiratory mask Jul. 07, 2015
  • Patent Title: Ventilation system and control thereof Jul. 07, 2015
  • Patent Title: Compact oronasal patient interface Jun. 30, 2015
  • Patent Title: Forehead support for a facial mask Jun. 23, 2015
  • Patent Title: Methods and apparatus for varying the back-up rate for a ventilator Jun. 09, 2015
  • Patent Title: Nasal mask system Jun. 02, 2015
  • Patent Title: Breathable gas apparatus with humidifier May. 26, 2015
  • Patent Title: Breathable gas apparatus with humidifier May. 26, 2015
  • Patent Title: Humidifier and/or flow generator for cpap device May. 26, 2015
  • Patent Title: Cushion for mask system May. 19, 2015
  • Patent Title: Mask system May. 19, 2015
  • Patent Title: Distinguishing closed and open respiratory airway apneas by complex admittance values May. 12, 2015
  • Patent Title: Headgear connection assembly for a respiratory mask assembly May. 12, 2015
  • Patent Title: Mask system May. 12, 2015
  • Patent Title: Patient interface structure and method/tool for manufacturing same Apr. 21, 2015
  • Patent Title: Patient interface systems Apr. 21, 2015
  • Patent Title: Flow generator message system Apr. 21, 2015
  • Patent Title: Positive airway pressure device Apr. 21, 2015
  • Patent Title: Ergonomic and adjustable respiratory mask assembly with cushion Apr. 07, 2015
  • Patent Title: Vent valve apparatus Apr. 07, 2015
  • Patent Title: Mask system Mar. 31, 2015
  • Patent Title: Nasal assembly Mar. 24, 2015
  • Patent Title: Method and apparatus for resolving upper airway obstruction, resistance or instability Mar. 24, 2015
  • Patent Title: Methods and devices for the detection of hypopnoea Mar. 24, 2015
  • Patent Title: Mask with gusset Mar. 17, 2015
  • Patent Title: Air delivery conduit Mar. 17, 2015
  • Patent Title: Modification of sympathetic activation and/or respiratory function Mar. 17, 2015
  • Patent Title: Method and apparatus for adjusting respiratory mask sealing force Mar. 03, 2015
  • Patent Title: Respiratory mask having gas washout vent and method for making the mask Mar. 03, 2015
  • Patent Title: Mask system with interchangeable headgear connectors Feb. 24, 2015
  • Patent Title: Forehead supports for facial masks Feb. 17, 2015
  • Patent Title: Headgear for masks Feb. 10, 2015
  • Patent Title: Mask system and method for constructing the same Feb. 10, 2015
  • Patent Title: Forehead supports for facial masks Feb. 03, 2015
  • Patent Title: Cushion to frame assembly mechanism Feb. 03, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to RMD from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RMD News

Recent insights relating to RMD

CNBC Recommendations

Recent picks made for RMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RMD

RMD Analyst Ratings

RMD Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RMD Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RMD stock a Buy, Sell, or Hold?

  • What is the price target for $RMD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RMD Top Shareholders
Shareholder
Shares Held
RMD Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RMD stock?

  • Who owns the most shares of $RMD stock?

  • What funds own $RMD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RMD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RMD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RMD

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

  • Address San Diego, CA
  • Market Cap 28.8 billion
  • Employees 10,600
  • Industrial Classification Surgical & Medical Instruments & Apparatus
ResMed Inc. Executive Compensation
Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation